Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ENDVOTCMKTS:LENSFOTCMKTS:MAGAANASDAQ:STSS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeENDVEndonovo Therapeutics$0.00+100.0%$0.00$0.00▼$0.00$120K-1.837.54 million shs500,002 shsLENSFPresbia$0.02$0.02$0.00▼$0.19$257K5.915,650 shsN/AMAGAAMagna-Lab$0.09$0.07$0.11▼$2.00$111K7.513,117 shs10 shsSTSSSharps Technology$5.49+1.9%$5.30$3.36▼$2,224.20$290K1.93396,205 shs32,311 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceENDVEndonovo Therapeutics+100.00%0.00%0.00%+100.00%-81.82%LENSFPresbia0.00%0.00%0.00%0.00%0.00%MAGAAMagna-Lab0.00%+24.74%+54.21%+90.89%-92.21%STSSSharps Technology+1.86%+0.92%+43.34%-56.74%+548,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationENDVEndonovo TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ALENSFPresbiaN/AN/AN/AN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/AN/AN/AN/ASTSSSharps Technology0.9993 of 5 stars0.02.00.00.03.81.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceENDVEndonovo Therapeutics 0.00N/AN/AN/ALENSFPresbia 0.00N/AN/AN/AMAGAAMagna-Lab 0.00N/AN/AN/ASTSSSharps Technology 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookENDVEndonovo Therapeutics$10K24.13N/AN/A($0.08) per share0.00LENSFPresbiaN/AN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/A($1.52) per shareN/ASTSSSharps TechnologyN/AN/AN/AN/A$110.01 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateENDVEndonovo Therapeutics-$2.80MN/A0.00∞N/AN/AN/AN/AN/ALENSFPresbiaN/AN/A0.00∞N/AN/AN/AN/AN/AMAGAAMagna-Lab-$130K$0.180.52∞N/AN/A-12.32%42,399.99%N/ASTSSSharps Technology-$9.30M-$1,881.93N/A∞N/AN/A-98.77%-53.85%N/ALatest MAGAA, STSS, LENSF, and ENDV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025STSSSharps TechnologyN/A$38.62N/A$38.62N/AN/A3/27/2025Q4 2024STSSSharps Technology-$198.00-$861.00-$663.00-$2.87$14.60 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthENDVEndonovo TherapeuticsN/AN/AN/AN/AN/ALENSFPresbiaN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/ASTSSSharps TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioENDVEndonovo TherapeuticsN/AN/AN/ALENSFPresbiaN/AN/AN/AMAGAAMagna-LabN/AN/AN/ASTSSSharps TechnologyN/A1.651.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipENDVEndonovo TherapeuticsN/ALENSFPresbiaN/AMAGAAMagna-LabN/ASTSSSharps Technology17.17%Insider OwnershipCompanyInsider OwnershipENDVEndonovo Therapeutics5.61%LENSFPresbia74.20%MAGAAMagna-Lab15.30%STSSSharps Technology1.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableENDVEndonovo Therapeutics11.21 billion1.14 billionNot OptionableLENSFPresbia2017.12 millionN/ANot OptionableMAGAAMagna-Lab201.18 millionN/ANot OptionableSTSSSharps Technology350,00053,000Not OptionableMAGAA, STSS, LENSF, and ENDV HeadlinesRecent News About These CompaniesSharps Technology Inc News (STSS) - Investing.comJune 26 at 3:42 PM | investing.comSharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility UpgradesJune 18, 2025 | globenewswire.comSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 11, 2025 | markets.businessinsider.comSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 11, 2025 | financialpost.comFSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 11, 2025 | globenewswire.comSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 10, 2025 | financialpost.comFSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 10, 2025 | globenewswire.comSharps Technology, Inc. CEO Robert Hayes to Present at Virtual Investor Summit on June 10, 2025June 9, 2025 | quiverquant.comQSharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025June 9, 2025 | globenewswire.comSharps Technology stock soars on first commercial shipmentsJune 4, 2025 | investing.comSharps Technology Shares Rise After New Shipments BeginJune 4, 2025 | marketwatch.comSharps Technology Begins Shipping Smart Safety SyringesJune 4, 2025 | tipranks.comSharps Technology, Inc. Begins Commercial Shipments of Smart Safety Syringes, Marking Revenue Generation MilestoneJune 4, 2025 | quiverquant.comQSharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase AgreementsJune 4, 2025 | globenewswire.comSharps Technology Regains Nasdaq ComplianceMay 22, 2025 | tipranks.comSharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing RuleMay 22, 2025 | globenewswire.comSharps Technology, Inc. CEO Robert Hayes to Present at Aegis Capital Corp. 2025 Virtual Conference on May 22May 21, 2025 | quiverquant.comQSharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22ndMay 21, 2025 | globenewswire.comSharps Technology Inc.May 17, 2025 | barrons.comSharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ SyringesMay 6, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMAGAA, STSS, LENSF, and ENDV Company DescriptionsEndonovo Therapeutics OTCMKTS:ENDV$0.0002 +0.00 (+100.00%) As of 06/26/2025 01:17 PM EasternEndonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.Presbia OTCMKTS:LENSF$0.02 0.00 (0.00%) As of 10/21/2022Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.Magna-Lab OTCMKTS:MAGAA$0.09 0.00 (0.00%) As of 06/25/2025Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.Sharps Technology NASDAQ:STSS$5.49 +0.10 (+1.86%) Closing price 06/26/2025 04:00 PM EasternExtended Trading$5.57 +0.08 (+1.46%) As of 06/26/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside Is IBM’s AI Transformation Powering a Sustained Rally? Analysts Supercharge AMD Stock Ahead of Q2 AI Catalyst Amazon: Why Some Are Growing Bearish, and Why They’re Wrong ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside Astera Labs: AI Infrastructure Play With Significant Growth Ahead Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
